Current membership charges are just £35 per year.
Choose from one, two or three years membership period at signup!
To organise at least one symposium per year To maintain a human resource directory To maintain a recommended reference/reading directory To facilitate research To be financially viable To liaise with other groups associated with care of patients with renal impairment To facilitate exchange of ideas and information To maintain an international perspective To facilitate training of pharmacists and other health care staff associated with care of patients with renal impairment To respond to educational and training requirements of membership as indicated by annual survey To maintain a renal drug file
This Medication Optimisation Toolkit can be used in conjunction with the ‘Acute Kidney Injury - Risk Assessment Proforma’ developed by the National AKI Delivery Group
We've added new online payment facilities, pay online for ease of use and continued website access
Member Profile Page
Are you unsure about dosing a particular drug on your renal unit or want to find out information on renal specific protocols? The UKRPG Q&A forum may be able to help. Post a question on the website, fellow renal pharmacists will be notified and may be able to answer your burning question.
Hi all, I know this was discussed previously but unable to find a definite answer - I have a HD patients who has resistant CMV and is being treated with foscarnet 6mg/kg tds, we are approaching the third week - do you usually cut down the dose to once daily after 3 weeks or do you continue with the ...
An HD patient from Germany is to have his dialysis at our hospital during the summer. At his hospital in Germany heparin is used in connection with the dialysis procedure while in Norway dalteparin 2500 IU - 5000 IU is used. Should we follow our local guideline or should we attempt to use heparin? ...